MedTrace Logo

Hypocholesterolemic Effect of Fibracep

NCT04545463 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-09-11

No results posted yet for this study

Summary

FIBRACEP is an onion based fiber that has demonstrated in vitro and in animal models the capacity to increase HDL cholesterol levels as well to improve other lipid profile species. This intervention aims to demonstrate FIBRACEP's blood lipid profile improvement effect. For that purpose, hypercholesterolemic subjects will be recruited and given a daily dose of 7 g of FIBRACEP for two months. Changes in blood lipid profile will be the end-point of the study.

Conditions

Interventions

DIETARY_SUPPLEMENT

FIBRACEP

A total intake of 7 g/day of FIBRACEP (provided in 6 cookies of 15 g/each) during two months

DIETARY_SUPPLEMENT

INSOLUBLE

A total intake of 7 g/day of wheat bran (provided in 6 cookies of 15 g/each) during two months

DIETARY_SUPPLEMENT

SOLUBLE

A total intake of 7 g/day of psyllium plantago (provided in 6 cookies of 15g/each) during two months

Sponsors & Collaborators

  • Universitat de Lleida

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-01
Primary Completion
2016-05-01
Completion
2016-05-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04545463 on ClinicalTrials.gov